Urate lowering therapy for patients with gout on hemodialysis

被引:0
|
作者
Alkilany, Reem [1 ,4 ]
Einstadter, Douglas [2 ,3 ]
Antonelli, Maria [1 ]
机构
[1] Case Western Reserve Univ, Metrohlth Med Ctr, Dept Med, Div Rheumatol, Cleveland, OH USA
[2] Case Western Reserve Univ, Ctr Hlth Care Res & Policy, Cleveland, OH USA
[3] Case Western Reserve Univ, Metrohlth Med Ctr, Dept Internal Med, Cleveland, OH USA
[4] Dept Rheumatol, 2500 Metrohlth Dr, Haman Bldg, 5th Floor, Cleveland, OH 44109 USA
关键词
ESRD; gout; hemodialysis; uric acid;
D O I
10.1111/1756-185X.14527
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:585 / 585
页数:1
相关论文
共 50 条
  • [41] Pharmacist-managed titration of urate-lowering therapy to streamline gout management
    Huang, Irvin J.
    Liew, Jean W.
    Morcos, Meredith B.
    Zuo, Silu
    Crawfords, Carol
    Bays, Alison M.
    RHEUMATOLOGY INTERNATIONAL, 2019, 39 (09) : 1637 - 1641
  • [42] Temporal evolution of urate crystal deposition over articular cartilage after successful urate-lowering therapy in patients with gout: An ultrasonographic perspective
    Das, Shyamashis
    Goswami, Rudra Prosad
    Ghosh, Alakendu
    Ghosh, Parasar
    Lahiri, Debasish
    Basu, Kaushik
    MODERN RHEUMATOLOGY, 2017, 27 (03) : 518 - 523
  • [43] Prediction of renal and cardiometabolic outcomes in gout during urate-lowering therapy by sonography
    Calabuig, Irene
    Marty-Ane, Anne
    Norberciak, Laurene
    Budzik, Jean-Francois
    Legrand, Julie
    Martinez-Sanchis, Agustin
    Pascart, Tristan
    Andres, Mariano
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2023, 26 (12) : 2450 - 2459
  • [44] Prophylaxis on gout flares after the initiation of urate-lowering therapy: a retrospective research
    Feng, Xin
    Li, Yao
    Gao, Wei
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 8 (11): : 21460 - 21465
  • [45] Determinants of the clinical outcomes of gout during the first year of urate-lowering therapy
    Becker, Michael A.
    MacDonald, Patricia A.
    Hunt, Barbara J.
    Lademacher, Christopher
    joseph-Ridge, Nancy
    NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS, 2008, 27 (6-7): : 585 - 591
  • [46] Effect of urate-lowering therapy on the velocity of size reduction of tophi in chronic gout
    Perez-Ruiz, F
    Calabozo, M
    Pijoan, J
    Herrero-Beites, AM
    Ruibal, A
    ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2002, 47 (04): : 356 - 360
  • [47] EFFICACY AND SAFETY OF A URATE LOWERING REGIMEN IN PRIMARY GOUT
    Bailen, Rebeca
    Gonzalez Senac, Nicolas M.
    Lopez, Monica M.
    Luisa Llena, M.
    Migoya, Marta
    Teresa Rodriguez, M.
    de Miguel, Eugenio
    Torres, Rosa J.
    Puig, Juan G.
    NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS, 2014, 33 (4-6): : 174 - 180
  • [48] Adherence with urate-lowering therapies for the treatment of gout
    Leslie R Harrold
    Susan E Andrade
    Becky A Briesacher
    Marsha A Raebel
    Hassan Fouayzi
    Robert A Yood
    Ira S Ockene
    Arthritis Research & Therapy, 11
  • [49] Pharmacist-managed titration of urate-lowering therapy to streamline gout management
    Irvin J. Huang
    Jean W. Liew
    Meredith B. Morcos
    Silu Zuo
    Carol Crawford
    Alison M. Bays
    Rheumatology International, 2019, 39 : 1637 - 1641
  • [50] Obesity reduces the urate-lowering efficacy among patients with primary gout: a prospective cohort study
    Cheng, Zan
    Xu, Xinmiao
    Qi, Han
    Li, Xiaoyu
    Li, Yushuang
    Jiang, Chang
    Miao, Xinyuan
    Ji, Xiaopeng
    Wang, Yunyang
    Dong, Bingzi
    Li, Changgui
    Lu, Jie
    RHEUMATOLOGY, 2025,